Mutations in the TP53 tumour suppressor gene are the most common genetic alterations in human cancers [2] and most can lead to the expression of mutant p53 proteins with a half-life longer than for the wild type, which then accumulate in cancer cells. This evidence concerns the gene TP53 and cancer.